SEC 13F Intelligence

Birchview Capital, LP / INBXUSD

Birchview Capital, LP’s Inhibrx Inc Position

Does Birchview Capital, LP own Inhibrx Inc (INBXUSD)? Not currently — the last reported position was 48.4K shares worth $2M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2024
Shares
48.4K
% of Portfolio
+1.38%
Quarters Held
10
position exited

Position History INBXUSD

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $1MQ2 ’22: $800,000Q2 ’22Q3 ’22: $1MQ4 ’22: $1,736Q4 ’22Q1 ’23: $1,329Q2 ’23: $2MQ2 ’23Q3 ’23: $1MQ4 ’23: $2MQ4 ’23Q1 ’24: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202448.4K$2M+1.38%
Q4 202348.4K$2M+1.44%
Q3 202370.4K$1M+1.10%
Q2 202370.4K$2M+1.37%
Q1 202370.4K$1,329+1.04%
Q4 202270.4K$1,736+1.23%
Q3 202270.4K$1M+0.89%
Q2 202270.4K$800,000+0.58%
Q1 202250.4K$1M+0.81%
Q4 202140.0K$2M+1.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of INBXUSD.